Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-13 8:50 pm Sale | 2025-03-11 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP, L.P. ("GP") | 1,184,570 5.400% | -260,000 (-18.00%) | Filing History |
| 2024-03-14 07:30 am Sale | 2024-03-12 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP, L.P. ("GP") | 1,444,570 6.900% | -232,855 (-13.88%) | Filing History |
| 2023-12-18 5:18 pm Sale | 2023-12-14 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP, L.P. ("GP") | 1,677,425 8.200% | -190,855 (-10.22%) | Filing History |
| 2023-08-17 6:22 pm Sale | 2023-08-16 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP, L.P. ("GP") | 1,868,280 9.200% | -200,000 (-9.67%) | Filing History |
| 2022-12-12 4:00 pm Purchase | 2022-12-01 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP, L.P. ("GP") | 2,068,280 11.800% | 2,068,280 (New Position) | Filing History |